JAN 15, 2019 12:00 AM SGT

Flexible manufacturing strategies for cell and gene therapy products

SPONSORED BY: TERUMO BCT
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Cell Processing Specialist, APAC Region, Terumo BCT
    Biography
      Wenyan Leong is a regional expert for the Cell Therapy Technologies portfolio of Terumo BCT. Responsible for managing knowledge transfer and implementation of efficient and safe manufacturing solutions in the biotechnology and cell therapy fields, Dr. Leong works closely with various industry representatives, researchers and clinicians throughout Asia Pacific. She is very passionate about the advances in cell- and gene-based therapy and seeks active dialogue with stakeholders in the field on bringing innovation to patients in need.

      Prior to joining Terumo BCT, Leong spent four productive years conducting academic research on cell-based regenerative medicine platforms, working on a variety of cell types and biomaterials. Her contribution of 10 research articles and three patents to this specialty resulted in a PhD in Bioengineering from Nanyang Technological University, Singapore.

    Abstract:

    DATE: January 15, 2019

    TIME:  4:00pm SGT

    There is a clear call to automate manufacturing for cell and gene therapy products, but when should you automate? In this session, we will consider the shifting priorities as you move from product development towards clinical manufacturing and discuss how choosing the right type of automation can create immediate impact without compromising flexibility. Case studies in adherent and suspension cell expansion, gene modification and cell secretome production will be presented.

    Who may be interested:

    • Clinicians, researchers, lab technologists and cell therapy industry professional
    • Cell and gene therapy manufacturing professionals
    • Contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs)

     

    Key learning objectives:

    • Understand the impact of Investigational New Drug submission on the manufacturing process
    • Learn how various adopters of the Quantum® Cell Expansion System have improved their manufacturing processes

    Show Resources
    You May Also Like
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    NOV 18, 2019 07:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 18, 2019 07:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    JUN 26, 2019 09:00 AM PDT
    C.E. CREDITS
    JUN 26, 2019 09:00 AM PDT
    DATE: June 26, 2019TIME: 9:00am PDT, 12:00pm EDT An excessive number of software solutions are available to help manage your clinical, biobank, or biorepository sample inform...
    Loading Comments...
    Show Resources